TH
Thermopylae Holdings Ltd. bought $699K of ABCL stock
Thermopylae Holdings Ltd., 10% owner of AbCellera Biologics Inc. (ABCL), bought 60,565 shares of ABCL stock worth $699K, per an SEC Form 4 filed Nov 12, 2026.
It was an open-market purchase.
The trade was reported on Nov 12, 2026.
ABCL has moved -1.1% since the trade date, from $11.62 to $11.49 (Nov 13, 2026 close).
- Traded
- Nov 12, 2026
- Disclosed
- Nov 12, 2026
- Filing delay
- 0 days
- Price since
- -1.1%
- Role
- 10% owner
- Source
- SEC Form 4